Effectiveness of β-Blockade in Experimental Chronic Aortic Regurgitation
Authors:
- 14 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (11) , 1477-1483
Abstract
Background— Past studies have suggested that the adrenergic system becomes abnormally activated in chronic volume overload, such as in severe aortic valve regurgitation (AR). However, the effectiveness of agents directed against this adrenergic activation has never been adequately tested in chronic AR. We therefore tested the effects of metoprolol treatment on the left ventricular (LV) function and remodeling in severe chronic AR in rats. Methods and Results— Severe AR was created in adult male Wistar rats by retrograde puncture of the aortic leaflets under echocardiographic guidance. Two weeks later, some animals received metoprolol treatment (25 mg/kg) orally for 24 weeks, and some were left untreated. LV dimensions, ejection fraction, and filling parameters were evaluated by echocardiography. Hearts were harvested at 1, 2, 14, and 180 days for the evaluation of hypertrophy, β-adrenergic receptor status, and extracellular matrix remodeling. We found that metoprolol treatment prevented LV dilatation and preserved the ejection fraction and filling parameters compared with untreated animals. Metoprolol increased the expression of β 1 -adrenoreceptor mRNA and reduced G protein receptor kinase 2 levels. Collagen I and III mRNA levels were reduced. Cardiac myocyte hypertrophy was also prevented. Conclusions— In our experimental model of severe AR, metoprolol treatment had a significant beneficial global effect on LV remodeling and function. These results suggest that the adrenergic system is important in the development of volume-overload cardiomyopathy in AR and that adrenergic-blocking agents may play a role in the treatment of this disease.Keywords
This publication has 25 references indexed in Scilit:
- The β-adrenergic receptor kinase in heart failureJournal of Molecular and Cellular Cardiology, 2003
- β-blocker therapy in patients after aortic valve replacement for aortic regurgitationInternational Journal of Cardiology, 2000
- Usefulness of .BETA. Blocker Therapy in Patients with Takayasu Arteritis and Moderate or Severe Aortic Regurgitation.Japanese Heart Journal, 2000
- Myocardialβ-adrenergic and Muscarinic Receptor Density in Cardiac Pressure or Volume OverloadJournal of Molecular and Cellular Cardiology, 1998
- Four years follow-up study in patients with Takayasu arteritis and severe aortic regurgitation; assessment by echocardiographyInternational Journal of Cardiology, 1996
- Comparison of the effect of left ventricular volume and pressure overload on β-adrenoceptor density in left heart valvular diseaseInternational Journal of Cardiology, 1996
- Clinical outcome of severe asymptomatic chronic aortic regurgitation: A long-term prospective follow-up studyAmerican Heart Journal, 1995
- Effect of the Angiotensin-converting Enzyme Inhibitor Alacepril on Ventricular Function and Beta-Adrenoceptor Number in Rabbits with Aortic Regurgitation.Japanese Heart Journal, 1995
- Abnormalities in sympathoneuronal regulation are localized to failing myocardium in rabbit heartJACC, 1994
- A simple method for producing graded aortic insufficiencies in rats and subsequent development of cardiac hypertrophyJournal of Pharmacological Methods, 1989